litlas
Log inCreate account

Roger G. Pertwee

Active 1970–2022

123
Papers
37,380
Citations
94
h-index
123
i10-index

Citations

Citations per year for Roger G. Pertwee1971: 3 citations1972: 7 citations1973: 6 citations1974: 3 citations1975: 4 citations1976: 1 citations1977: 2 citations1978: 1 citations1979: 1 citations1980: 2 citations1981: 6 citations1982: 1 citations1983: 2 citations1984: 1 citations1985: 2 citations1986: 3 citations1987: 3 citations1988: 4 citations1989: 1 citations1990: 4 citations1991: 6 citations1992: 10 citations1993: 25 citations1994: 27 citations1995: 81 citations1996: 95 citations1997: 115 citations1998: 242 citations1999: 230 citations2000: 274 citations2001: 359 citations2002: 485 citations2003: 419 citations2004: 337 citations2005: 525 citations2006: 443 citations2007: 480 citations2008: 408 citations2009: 414 citations2010: 420 citations2011: 439 citations2012: 422 citations2013: 340 citations2014: 328 citations2015: 410 citations2016: 411 citations2017: 450 citations2018: 352 citations2019: 1,129 citations2020: 1,355 citations2021: 1,146 citations2022: 769 citations2023: 481 citations2024: 693 citations2025: 255 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,752 citing papers, 28.6% of this breakdownItaly: 962 citing papers, 10% of this breakdownUnited Kingdom: 812 citing papers, 8.4% of this breakdownSpain: 516 citing papers, 5.4% of this breakdownCanada: 497 citing papers, 5.2% of this breakdownGermany: 447 citing papers, 4.6% of this breakdownAustralia: 320 citing papers, 3.3% of this breakdownBrazil: 263 citing papers, 2.7% of this breakdownFrance: 253 citing papers, 2.6% of this breakdownChina: 246 citing papers, 2.6% of this breakdownIsrael: 244 citing papers, 2.5% of this breakdownJapan: 213 citing papers, 2.2% of this breakdown
0%28.6%Other 21.9%

Institutions

Fields

  • Medicine85.1%
  • Biochemistry, Genetics and Molecular Biology5.3%
  • Neuroscience5.1%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Agricultural and Biological Sciences0.6%
  • Immunology and Microbiology0.5%
  • Other2.3%

Topics

  • Cannabis and Cannabinoid Research28.1%
  • Neuroscience and Neuropharmacology Research8.4%
  • Neurotransmitter Receptor Influence on Behavior6.8%
  • Sleep and Wakefulness Research4.7%
  • Forensic Toxicology and Drug Analysis4.1%
  • GABA and Rice Research3%
  • Other44.9%

Coauthors

All papers

Open in search
  1. The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

    Authors: Roger G. Pertwee - British Journal of Pharmacology 2007 cited by 1,894

  2. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

    Authors: William A. Devane, Lumir Hanuš, Aviva Breuer, Roger G. Pertwee, Lesley Stevenson, Graeme Griffin, Dan Gibson, Asher Mandelbaum, Alexander Etinger, Raphael Mechoulam - Science 1992 cited by 5,647

  3. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

    Authors: Raphael Mechoulam, Shimon Ben‐Shabat, L Hanŭs, M. Ligumsky, Norbert E. Kaminski, Anthony R. Schatz, Asher Gopher, Shlomo Almog, Billy R. Martin, David R. Compton, Roger G. Pertwee, Graeme Griffin, Michael Bayewitch, Jacob Barg, Zvi Vogel - Biochemical Pharmacology 1995 cited by 2,901

  4. Cannabidiol displays unexpectedly high potency as an antagonist of CB1and CB2receptor agonistsin vitro

    Authors: Adèle Thomas, Gemma L. Baillie, Angela M. Phillips, Raj K. Razdan, Ruth A. Ross, Roger G. Pertwee - British Journal of Pharmacology 2007 cited by 749

  5. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

    Authors: Roger G. Pertwee, A­llyn C. Howlett, Mary E. Abood, S P H Alexander, Vincenzo Di Marzo, Maurice R. Elphick, Peter J. Greasley, Harald S. Hansen, George Kunos, Ken Mackie, Raphael Mechoulam, Ruth A. Ross - Pharmacological Reviews 2010 cited by 1,583

  6. Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

    Authors: John M. McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G. Pertwee - British Journal of Pharmacology 2014 cited by 520

  7. Cannabinoid pharmacology: the first 66 years

    Authors: Roger G. Pertwee - British Journal of Pharmacology 2006 cited by 774

  8. Endocannabinoids and Their Pharmacological Actions

    Authors: Roger G. Pertwee - Handbook of experimental pharmacology 2015 cited by 292

  9. Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1Areceptor antagonist

    Authors: M. G. Cascio, LA Gauson, L. A. Stevenson, RA Ross, Roger G. Pertwee - British Journal of Pharmacology 2009 cited by 231

  10. Symptom‐relieving and neuroprotective effects of the phytocannabinoid Δ9‐THCV in animal models of Parkinson's disease

    Authors: Concepción García, Cristina Palomo‐Garo, Moisés Garcı́a-Arencibia, Jaime A. Ramos, Roger G. Pertwee, Javier Fernández‐Ruíz - British Journal of Pharmacology 2011 cited by 208

  11. Pharmacology of cannabinoid CB1 and CB2 receptors

    Authors: Roger G. Pertwee - Pharmacology & Therapeutics 1997 cited by 1,474

  12. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

    Authors: Javier Fernández‐Ruíz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger G. Pertwee, Raphael Mechoulam, José Martínez‐Orgado - British Journal of Clinical Pharmacology 2012 cited by 343

  13. Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+Levels

    Authors: Duncan Ryan, Alison J. Drysdale, Carlos Lafourcade, Roger G. Pertwee, Bettina Platt - Journal of Neuroscience 2009 cited by 250

  14. HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor

    Authors: L Hanŭs, Aviva Breuer, Susanna Tchilibon, S. Shiloah, Dalia Goldenberg, Mark Horowitz, Roger G. Pertwee, Ruth A. Ross, Raphael Mechoulam, Ester Fride - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 568

  15. Early phytocannabinoid chemistry to endocannabinoids and beyond

    Authors: Raphael Mechoulam, Lumír O. Hanuš, Roger G. Pertwee, A­llyn C. Howlett - Nature reviews. Neuroscience 2014 cited by 382

  16. Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

    Authors: EM Rock, Daniele Bolognini, CL Limebeer, M. G. Cascio, Sharon Anavi‐Goffer, Paul Fletcher, Raphael Mechoulam, Roger G. Pertwee, LA Parker - British Journal of Pharmacology 2011 cited by 253

  17. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

    Authors: Katarzyna Z. Maresz, Gareth Pryce, Eugene D. Ponomarev, Giovanni Marsicano, J. Ludovic Croxford, Leah P. Shriver, Catherine Ledent, Xiaodong Cheng, Erica J. Carrier, Monica Mann, Gavin Giovannoni, Roger G. Pertwee, Takashi Yamamura, Nancy E. Buckley, Cecilia J. Hillard, Beat Lutz, David Baker, Bonnie N. Dittel - Nature Medicine 2007 cited by 362

  18. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

    Authors: Barbara Romano, Francesca Borrelli, Ines Fasolino, Raffaele Capasso, Fabiana Piscitelli, M. G. Cascio, Roger G. Pertwee, Diana Coppola, L.M. Vassallo, Pierangelo Orlando, Vincenzo Di Marzo, Angelo A. Izzo - British Journal of Pharmacology 2013 cited by 175

  19. Cannabinoid receptors and pain

    Authors: Roger G. Pertwee - Progress in Neurobiology 2001 cited by 740

  20. Allosteric Modulation of the Cannabinoid CB1 Receptor

    Authors: M. R. Price, Gemma L. Baillie, Adèle Thomas, Lesley Stevenson, Morag Easson, Richard Goodwin, Adèle McLean, Lorraine McIntosh, Gillian Goodwin, Glenn Walker, Paul Westwood, Julia Marrs, Fiona Thomson, Phillip M. Cowley, Arthur Christopoulos, Roger G. Pertwee, Ruth A. Ross - Molecular Pharmacology 2005 cited by 447

  21. Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences

    Authors: J M McPartland, Michelle Glass, Roger G. Pertwee - British Journal of Pharmacology 2007 cited by 265

  22. Evidence that the plant cannabinoid Δ9‐tetrahydrocannabivarin is a cannabinoid CB1and CB2receptor antagonist

    Authors: Adèle Thomas, Lesley Stevenson, Kerrie N Wease, M. R. Price, Gemma L. Baillie, Ruth A. Ross, Roger G. Pertwee - British Journal of Pharmacology 2005 cited by 175

  23. The pharmacology of cannabinoid receptors and their ligands: an overview

    Authors: Roger G. Pertwee - International Journal of Obesity 2006 cited by 555

  24. Emerging strategies for exploiting cannabinoid receptor agonists as medicines

    Authors: Roger G. Pertwee - British Journal of Pharmacology 2009 cited by 431